Liver Diseases  >>  Xifaxan (rifaximin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health
NCT01069133: Study of Rifaximin in Minimal Hepatic Encephalopathy

Completed
1/2
20
US
Rifaximin, xifaxan, rifaximin
Hunter Holmes Mcguire Veteran Affairs Medical Center, Bausch Health Americas, Inc.
Minimal Hepatic Encephalopathy
05/12
12/12

Download Options